论文部分内容阅读
Many leukemia cells highly express chemokine receptor of CXCR4 that actively responses to CXCL12 constitutively secreted by stromal cells or endothelial cells in the bone marrow and many organs.Activation of CXCR4 induces leukemia cells trafficking and homing to the marrow microenvironment or metastasis to target organs, where CXCL12 retains leukemia cells in close contact with stromal cells and endothelial cells that provide protection from chemotherapy In this study, we report one novel CXCR4 antagonist peptide (P3) screened from 20 small synthesized peptides targeting to human CXCR4.